Cargando…

Wild type microglia arrest pathology in a mouse model of Rett syndrome

Rett syndrome is an X-linked autism spectrum disorder. The disease is characterized in the majority of cases by mutation of the MECP2 gene, which encodes a methyl-CpG-binding protein (1–5). Although MeCP2 is expressed in many tissues, the disease is generally attributed to a primary neuronal dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales: Derecki, Noël C., Cronk, James C., Lu, Zhenjie, Xu, Eric, Abbott, Stephen B. G., Guyenet, Patrice G., Kipnis, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321067/
https://www.ncbi.nlm.nih.gov/pubmed/22425995
http://dx.doi.org/10.1038/nature10907
_version_ 1782228910492090368
author Derecki, Noël C.
Cronk, James C.
Lu, Zhenjie
Xu, Eric
Abbott, Stephen B. G.
Guyenet, Patrice G.
Kipnis, Jonathan
author_facet Derecki, Noël C.
Cronk, James C.
Lu, Zhenjie
Xu, Eric
Abbott, Stephen B. G.
Guyenet, Patrice G.
Kipnis, Jonathan
author_sort Derecki, Noël C.
collection PubMed
description Rett syndrome is an X-linked autism spectrum disorder. The disease is characterized in the majority of cases by mutation of the MECP2 gene, which encodes a methyl-CpG-binding protein (1–5). Although MeCP2 is expressed in many tissues, the disease is generally attributed to a primary neuronal dysfunction (6). However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology. Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome. Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development. However, when cranial irradiation was blocked by lead shield, and microglial engraftment was prevented, disease was not arrested. Similarly, targeted expression of Mecp2 in myeloid cells, driven by Lysm(cre) on an Mecp2-null background, dramatically attenuated disease symptoms. Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved. Mecp2(+/−) females also exhibited significant improvements as a result of wild type microglial engraftment. These benefits mediated by wild type microglia, however, were diminished when phagocytic activity was inhibited pharmacologically using annexin V to block phosphatydilserine residues on apoptotic targets, thus preventing recognition and engulfment by tissue-resident phagocytes. These results suggest the importance of microglial phagocytic activity in Rett syndrome. Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.
format Online
Article
Text
id pubmed-3321067
institution National Center for Biotechnology Information
language English
publishDate 2012
record_format MEDLINE/PubMed
spelling pubmed-33210672012-10-05 Wild type microglia arrest pathology in a mouse model of Rett syndrome Derecki, Noël C. Cronk, James C. Lu, Zhenjie Xu, Eric Abbott, Stephen B. G. Guyenet, Patrice G. Kipnis, Jonathan Nature Article Rett syndrome is an X-linked autism spectrum disorder. The disease is characterized in the majority of cases by mutation of the MECP2 gene, which encodes a methyl-CpG-binding protein (1–5). Although MeCP2 is expressed in many tissues, the disease is generally attributed to a primary neuronal dysfunction (6). However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology. Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome. Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development. However, when cranial irradiation was blocked by lead shield, and microglial engraftment was prevented, disease was not arrested. Similarly, targeted expression of Mecp2 in myeloid cells, driven by Lysm(cre) on an Mecp2-null background, dramatically attenuated disease symptoms. Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved. Mecp2(+/−) females also exhibited significant improvements as a result of wild type microglial engraftment. These benefits mediated by wild type microglia, however, were diminished when phagocytic activity was inhibited pharmacologically using annexin V to block phosphatydilserine residues on apoptotic targets, thus preventing recognition and engulfment by tissue-resident phagocytes. These results suggest the importance of microglial phagocytic activity in Rett syndrome. Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder. 2012-03-18 /pmc/articles/PMC3321067/ /pubmed/22425995 http://dx.doi.org/10.1038/nature10907 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Derecki, Noël C.
Cronk, James C.
Lu, Zhenjie
Xu, Eric
Abbott, Stephen B. G.
Guyenet, Patrice G.
Kipnis, Jonathan
Wild type microglia arrest pathology in a mouse model of Rett syndrome
title Wild type microglia arrest pathology in a mouse model of Rett syndrome
title_full Wild type microglia arrest pathology in a mouse model of Rett syndrome
title_fullStr Wild type microglia arrest pathology in a mouse model of Rett syndrome
title_full_unstemmed Wild type microglia arrest pathology in a mouse model of Rett syndrome
title_short Wild type microglia arrest pathology in a mouse model of Rett syndrome
title_sort wild type microglia arrest pathology in a mouse model of rett syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321067/
https://www.ncbi.nlm.nih.gov/pubmed/22425995
http://dx.doi.org/10.1038/nature10907
work_keys_str_mv AT dereckinoelc wildtypemicrogliaarrestpathologyinamousemodelofrettsyndrome
AT cronkjamesc wildtypemicrogliaarrestpathologyinamousemodelofrettsyndrome
AT luzhenjie wildtypemicrogliaarrestpathologyinamousemodelofrettsyndrome
AT xueric wildtypemicrogliaarrestpathologyinamousemodelofrettsyndrome
AT abbottstephenbg wildtypemicrogliaarrestpathologyinamousemodelofrettsyndrome
AT guyenetpatriceg wildtypemicrogliaarrestpathologyinamousemodelofrettsyndrome
AT kipnisjonathan wildtypemicrogliaarrestpathologyinamousemodelofrettsyndrome